Kenvue Gains 0.74% on Strategic Shifts and Share Buybacks as $510M Volume Ranks 193rd in U.S. Equities

On September 12, 2025, , . equities. The stock's performance followed a strategic update highlighting its focus on expanding over-the-counter healthcare product distribution in emerging markets.

Recent developments underscored Kenvue's commitment to optimizing its supply chain through automation investments, . .

, announced in early September, . This move has been interpreted as a confidence-building strategy amid broader sector volatility in consumer healthcare stocks.

To run this back-test robustly I need to pin down a few practical details: 1. Universe • Which market(s) should I draw the stocks from – all U.S. listed equities, only those in a specific index (e.g., Russell 3000, S&P 1500), or another universe? 2. Volume metric • Rank by share volume or by dollar volume (volume × close price)? 3. , or value-weight? • Any constraints on slippage/transaction costs you would like applied? 4. Benchmark (optional) • Would you like the results compared with a particular benchmark (e.g., SPY)? .